A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence (OPTIMA)
Urinary Incontinence
About this trial
This is an interventional health services research trial for Urinary Incontinence focused on measuring Practice-based intervention, Patient-centered outcomes research, Disparities, Quality of care indicators, Primary care, Urinary incontinence, Stress incontinence, Urge incontinence, Mixed incontinence, Overactive bladder
Eligibility Criteria
Inclusion Criteria of Primary Care Physicians:
- Primary care physician belonging to a recruited office among one of four participating sites: Cedars-Sinai, Harbor-UCLA, UCLA, UCSD
Inclusion Criteria of Patients
- Age >18 y/o
- English or Spanish fluency
- Female
- Answers "yes" to incontinence screening tool and agrees to participate
Exclusion Criteria of Primary Care Physicians:
- Non-primary care specialty
- Does not belong to one of the participating offices
Exclusion Criteria of Patients
- Age <18 y/o
- Answers "no" to incontinence screening tool and/or does not agree to participate
- Primary care provider (who reviews a list of patients that screen positive) deems patient ineligible due to pregnant, severe memory impairment, or psychiatric history preventing participation
Sites / Locations
- University of California, San DiegoRecruiting
- Cedars-SinaiRecruiting
- University of California, Los AngelesRecruiting
- Harbor-UCLA Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Practice-Based Intervention
Control
The intervention will include physician education, electronic decision support, implementation of an electronic referral system, and patient education/co-management by an advance practice provider.
Offices in this group will not receive the four-pronged intervention. However, after the study trial, there will be a "validation phase" in which the initial control group will then receive the intervention. This cross-over deign will then allow all 60 offices to receive the intervention. Data from the cross-over intervention group will be analyzed as a separate cohort to confirm improvements in patient care and outcomes as measured in the intervention group under the study trial can be duplicated.